Your browser doesn't support javascript.
loading
Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
Hack, Benjamin; Timalsina, Utsav; Tefera, Eshetu; Wilkerson, Brittany; Paku, Emily; Fernandez, Stephen; Fishbein, Dawn.
Affiliation
  • Hack B; Georgetown University Medical School, Washington, DC, USA.
  • Timalsina U; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Tefera E; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Wilkerson B; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Paku E; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Fernandez S; MedStar Health Research Institute, Hyattsville, MD, USA.
  • Fishbein D; MedStar Health Research Institute, Hyattsville, MD, USA.
J Prim Care Community Health ; 12: 21501327211034379, 2021.
Article in En | MEDLINE | ID: mdl-34467805
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Opioid-Related Disorders Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Prim Care Community Health Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Opioid-Related Disorders Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Prim Care Community Health Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States